A Phase 1 study of fianlimab in combination with cemiplimab in patients with anti–PD-1/L1-experienced cutaneous squamous cell carcinoma
Titel:
A Phase 1 study of fianlimab in combination with cemiplimab in patients with anti–PD-1/L1-experienced cutaneous squamous cell carcinoma
Auteur:
Kaczmar, J. Papadopoulos, K. Ansstas, G. Birnbaum, A. Mehnert, J. Hamid, O. Hughes, B. Rabinowits, G. Wei, A. Yushak, M. Mani, J. Fang, F. Wang, J. Kroog, G. Salvati, M. Lowy, I. Fury, M. Lakhani, N.J.